Información: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Información:
Error:
ID
10187
Descripción
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Palabras clave
Versiones (5)
- 2015-03-05 2015-03-05 -
- 2015-03-09 2015-03-09 -
- 2015-04-24 2015-04-24 -
- 2015-12-15 2015-12-15 -
- 2016-02-11 2016-02-11 -
Subido en
24 april 2015
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
End of Study Date
Item
End of Study Date
date
C2983670 (UMLS CUI-1)
CL Item
regular End of Study (0)
C0205272 (UMLS CUI-1)
CL Item
no CR after Induction (Progressive Disease) (1)
C1335499 (UMLS CUI-1)
CL Item
exzessive extramedullary medical toxicity (2)
C0013221 (UMLS CUI-1)
CL Item
dead (3)
C1306577 (UMLS CUI-1)
CL Item
relapse after CR (4)
C0035020 (UMLS CUI-1)
CL Item
Withdrawal of informed consent (5)
C1710677 (UMLS CUI-1)
CL Item
Protocol deviation (6)
C1705236 (UMLS CUI-1)
CL Item
other (7)
C0205394 (UMLS CUI-1)
Specify if Reason for End of Study = 6 or 7
Item
Specify if Reason for End of Study = 6 or 7
text
Induction therapy I administered
Item
Induction therapy I administered
boolean
C0857127 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
C0205447 (UMLS CUI-2)
Induction therapy II administered
Item
Induction therapy II administered
boolean
C0857127 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
C0205448 (UMLS CUI-2)
Consolidation therapy I administered
Item
Consolidation therapy I administered
boolean
C1511484 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
C0205447 (UMLS CUI-2)
Consolidation therapy II administered
Item
Consolidation therapy II administered
boolean
C1511484 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
C0205448 (UMLS CUI-2)
Consolidation therapy III administered
Item
Consolidation therapy III administered
boolean
C1511484 (UMLS CUI-1)
C0205449 (UMLS CUI-2)
C0205449 (UMLS CUI-2)
Consolidation therapy IV administered
Item
Consolidation therapy IV administered
boolean
C1511484 (UMLS CUI-1)
C0205450 (UMLS CUI-2)
C0205450 (UMLS CUI-2)
Maintenance therapy administered
Item
Maintenance therapy administered
boolean
C0677908 (UMLS CUI-1)
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)